Type 2 Diabetes Clinical Trial
Official title:
Exercise and Type 2 Diabetes: Gender and Endothelial Function
The objective of the current proposal is to evaluate the importance of blood vessel
dysfunction and heart dysfunction to overall exercise impairments in type 2 diabetes and
their contribution to the gender differences observed in exercise capacity. Importantly,
treatments that improve blood vessel function in persons with type 2 diabetes can be used to
directly assess whether impairment in blood vessel function and ultimately exercise
performance, can be improved and whether the degree of improvement differs between the
sexes.
Hypothesis 1. Uncomplicated type 2 diabetes more adversely affects exercise capacity in
women than men.
Hypothesis 2. Blood vessel function and cardiac function are more significantly impaired in
women with type 2 diabetes than men and contribute to the gender differences in exercise
capacity.
Hypothesis 3. Restoration of blood vessel function will improve exercise capacity more in
women than men with type 2 diabetes.
Subjects will come in for a total of seven research visits. Four initial study visits before
exercise training for three months and then subjects will repeat the testing.
1. Initial exam. A history and physical exam will be performed. Blood will be drawn for
measurements of overall health. Resting electrocardiogram will be obtained. The Low
Level Physical Activity Recall (LOPAR) questionnaire will be administered.
2. Dual Energy X-ray Absorptiometry (DEXA) will be carried out during visit two. A
familiarization bicycle ergometer test will also be performed on this day.
3. During visit three, a euglycemic clamp will be performed.
4. During visit four, echocardiographic measurements will be made and a diet interview
will be performed.
5. On visit five, measures of blood vessel-dependent vasodilation will be performed.
Repeated brachial artery diameter and forearm blood flow responses to cuff occlusion
will be measured separately on this occasion.
6. On visit six, arterial stiffness will be measured. Subjects will also perform a graded
bicycle exercise test.
7. On visit seven, subjects will perform constant level bicycle tests.
;
Intervention Model: Single Group Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
| Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
| Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
| Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
| Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
| Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
| Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
| Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
| Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
| Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
| Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
| Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
| Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
| Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |